KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Work In Process (2016)

AbbVie (ABBV) has disclosed Work In Process for 5 consecutive years, with $1.1 billion as the latest value for Q2 2016.

  • Quarterly Work In Process rose 4.81% to $1.1 billion in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Jun 2016, up 4.81% year-over-year, with the annual reading at $1.1 billion for FY2015, 71.86% up from the prior year.
  • Work In Process for Q2 2016 was $1.1 billion at AbbVie, down from $1.1 billion in the prior quarter.
  • The five-year high for Work In Process was $1.1 billion in Q1 2016, with the low at $262.0 million in Q1 2013.
  • Average Work In Process over 5 years is $672.0 million, with a median of $568.0 million recorded in 2015.
  • The sharpest move saw Work In Process soared 122.85% in 2015, then increased 4.81% in 2016.
  • Over 5 years, Work In Process stood at $286.0 million in 2012, then soared by 41.26% to $404.0 million in 2013, then soared by 55.69% to $629.0 million in 2014, then soared by 71.86% to $1.1 billion in 2015, then decreased by 1.2% to $1.1 billion in 2016.
  • According to Business Quant data, Work In Process over the past three periods came in at $1.1 billion, $1.1 billion, and $1.1 billion for Q2 2016, Q1 2016, and Q4 2015 respectively.